Finance

Beta
Ask
Lists
BCTX:NASDAQ
Briacell Therapeutics Corp
$2.74
-4.86%
(-0.14) 1D
$2.79
+1.82% (+0.050)
After hours
Closed: Jun 11, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BCTX...
Open
$2.86
High
$2.92
Low
$2.60
Mkt. cap
33.49M
Avg. vol.
249.79K
Volume
0.00
52-wk high
$36.00
52-wk low
$2.60
Beta
1.21
Shares outstanding
8.70M
No. of employees
22
Open
$2.86
High
$2.92
Low
$2.60
Mkt. cap
33.49M
Avg. vol.
249.79K
Volume
0.00
52-wk high
$36.00
52-wk low
$2.60
Beta
1.21
Shares outstanding
8.70M
No. of employees
22
News stories
From sources across the web
About Briacell Therapeutics Corp
CEO-
Employees22
Founded2006
HeadquartersWest Vancouver, British Columbia, Canada
SectorBiotechnology
Websitebriacell.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.00M
6.56M
5.92M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.56M
1.76M
1.61M
-
Operating expense
8.55M
8.32M
7.53M
-
Total operating expenses
8.55M
8.32M
7.53M
-
Operating income
-8.55M
-8.32M
-7.53M
-
Other non operating income
392.34K
-69.20K
211.78K
-
EBT including unusual items
-8.16M
-8.28M
-7.30M
-
EBT excluding unusual items
-8.22M
-8.37M
-7.30M
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.09M
-8.20M
-7.22M
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
33.44K
48.48K
105.64K
-
Interest expense
-
-
-
-
Net interest expenses
33.44K
48.48K
105.64K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.53M
-8.30M
-7.50M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer